Shares of Acasti Pharma Inc (NASDAQ: ACST), which closed at $2.18 Friday, have entered penny stock territory after a negative data readout. Placebo Effect Impacts Acasti’s Results Acasti released …
More Acasti Shares Slump On Failed Late-Stage Trial, Amarin Moves In Sympathy Videos